Market Share

A new AI tool is shifting post-acute care from relationship-based referrals to data-driven strategy by analyzing entire physician groups, not just doctors.

In the chaotic, high-stakes world of pharma tradeshows, success is no longer about free pens. It's about strategy, psychology, and navigating regulations.

As Mount Pleasant Group marks its 200th anniversary, it's deploying goats and bees to manage historic grounds, transforming spaces of remembrance into vibrant ecosystems.

With the hire of 35-year veteran James McNeill, Infinity Aviation signals a bold strategy to scale its operations and challenge giants in the FBO market.

At Automate 2026, Taiwan isn't just selling robots. It's offering a strategic partnership to rebuild U.S. manufacturing with its advanced AI and automation.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Netflix's expanded iHeartMedia deal isn't just about more shows; it's a calculated move to conquer daytime viewing and redefine streaming engagement.

Jeep revives the Trailhawk and Overland, but the real story is a calculated move by Stellantis to reinforce its core brand identity in a shifting market.

A new data-driven framework aims to move senior living beyond bingo attendance, tackling the silent epidemic of loneliness. But can technology truly measure connection?

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

New research reveals why employees bypass corporate travel tools: they can't find what they need. This 'invisible spend' is costing firms millions.

Stunning new US/EU data for BTK inhibitor orelabrutinib signals a major push into Western markets, challenging established blood cancer therapies.

SINTRONES unveils rugged Edge AI at EUROSATORY 2026, processing data on the front lines. This move toward decentralized intelligence and data sovereignty redefines resilience.

While Nevada's cannabis market contracts, C21 Investments posts record customer growth and an 8% revenue jump, fueled by a high-stakes tax challenge.

As the utility-scale solar industry grapples with labor shortages and tight deadlines, one Texas firm is sharpening its message: execution is everything.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

Beyond solar panels and ESG reports, JFK's $9.5B New Terminal One is a blueprint for climate-proof infrastructure. Here’s why it redefines the 2026 travel experience.